Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Granules India Gets U.S. FDA Approval for Generic Naproxen

Sept. 23 (Bloomberg) -- Granules India Ltd. received approval from the U.S. Food and Drug Administration for its naproxen sodium tablet, the generic version of Bayer AG’s Aleve pain relieving medicine, according to a statement on the regulator’s website.

Link to Company News:{3400398Z US <Equity> CN <GO>} Link to Company News:{BAYN GR <Equity> CN <GO>} Link to Company News:{GRAN IN <Equity> CN <GO>}

To contact the reporter on this story: Adi Narayan in Mumbai at

To contact the editor responsible for this story: Niveditha Ravi at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.